Ibrutinib vs. Acalabrutinib: I’m going to ask my... - CLL Support
Ibrutinib vs. Acalabrutinib
You need to be a member of this community to see this post.
Read more about...
42 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Encouraging results from son of Ibrutinib studies (Acalabrutinib/Calquence)
In case you need any more persuasion that we are in exiting times for the future of CLL, read this...
Acalabrutinib vs Ibrutinib
I have been on ibrutinib 140 mg for B cell lymphoma for 18 months my wbc count down from 60k to 14k...
Cardiotoxicity in patients treated with acalabrutinib
The latest edition of the journal Blood has two articles that highlight the issue of cardiotoxicity...
A Conversation with Dr Tam about Zanubrutinib: A Novel BTK Inhibitor
How does zanubrutinib differ from ibrutinib in pharmacokinetics and target occupancy?
Zanubrutinib...
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...
Related Posts
Early use of Ibrutinib or is W&W still a needed strategy?- Second-Generation BTK Inhibitors Hit the Treatment Bullseye With Fewer Off-Target Effects
- Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory CLL
Changing from ibrutinib to acalabrutinib- Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
